Development of an implementation-ready antihypertensive self-titration intervention to improve US blood pressure control
开发可立即实施的抗高血压自我滴定干预措施,以改善美国血压控制
基本信息
- 批准号:10676839
- 负责人:
- 金额:$ 17.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-04 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdherenceAdoptionAdultAlgorithmsAntihypertensive AgentsAreaBiometryBlood PressureCardiologyCardiometabolic DiseaseCardiovascular DiseasesCardiovascular systemCaringCessation of lifeCharacteristicsChargeClinicClinicalCoronary heart diseaseCrystallizationDataData SetDevelopmentDiagnosisDiseaseDisease ManagementEffectivenessEffectiveness of InterventionsEnsureEnvironmentEquipoiseEvidence based treatmentFamily memberGoalsGrantGuidelinesHealth Services ResearchHeart failureHomeHypertensionImmersionImplementation readinessInfrastructureInterventionInterviewLeadershipLiteratureMentorsMentorshipMissionModelingMonitorMorbidity - disease rateMyocardial InfarctionNational Heart, Lung, and Blood InstitutePatient CarePatient PreferencesPatientsPatternPharmaceutical PreparationsPopulationPreventionPreventivePrimary CarePrimary Care PhysicianProtocols documentationProviderPublishingQualitative MethodsRandomizedReactionRecommendationRegimenResearchResearch MethodologyReview LiteratureRisk ReductionSelf EfficacySelf ManagementStrokeStructureTestingTitrationsTrainingWorkWritingblood pressure controlblood pressure reductioncareercareer developmentcostcost effectivenessdesigndisorder preventioneffectiveness testingfollow-uphypertension controlhypertension treatmentimplementation designimplementation facilitatorsimplementation scienceimprovedinnovationmedication compliancemedication nonadherencemortalitynovel strategiespatient orientedpractice factorsprimary care practiceprimary care settingprogramsprovider factorsrandomized trialroutine careroutine practicesociodemographicssystematic reviewteam-based caretreatment choicetreatment guidelinesusability
项目摘要
Nearly 1 in 2 US adults has hypertension, and it is a leading cause of myocardial infarction,
stroke, and death. Despite the importance of hypertension and the widespread availability of
medication treatment, only 44% of patients had controlled blood pressures in 2018. This is in
part due to the way in which we deliver care, and new strategies are needed to achieve better
blood pressure control. Team-based care with medication titration by a non-physician is a
promising approach, but the cost and infrastructure required make this option less feasible. An
alternative strategy is to have patients self-manage their own hypertension by checking blood
pressures and following an algorithm, pre-planned between the patient and primary care doctor,
to intensify their medications at home. Despite evidence for the effectiveness and cost-
effectiveness of this approach, it has not yet been incorporated into routine care.
In this project, we propose to develop an implementation-ready antihypertensive self-titration
intervention informed by qualitative interviews and real-world assessments of antihypertensive
adherence. The proposed aims are to: (1) explore barriers and facilitators to the implementation
of antihypertensive self-titration in routine US primary care; (2) assess adherence to
antihypertensive treatments; and (3) develop an implementation-ready antihypertensive self-
titration protocol, perform usability testing, and prepare a proposal for a pragmatic, randomized
trial to test the intervention’s effectiveness. The overarching goal of the project is to develop an
innovative alternative model of hypertension care that has the potential to improve blood
pressure control, patient self-efficacy, and disease understanding
Dr. Haff is a practicing primary care physician committed to a career in research to improve the
prevention and treatment of cardiometabolic disease, and this proposal includes a training plan
that will accelerate her career development in the areas of implementation science, qualitative
methods, health services research methods, and scientific writing. The mentorship team, led by
Niteesh Choudhry, an expert in health services research and implementation science related to
cardiometabolic disease, includes well-known experts in preventive cardiology (Paul Ridker, co-
mentor), biostatistics (Robert Glynn, co-mentor), and implementation science and qualitative
methods (Karen Emmons, co-mentor), and will ensure successful completion of the proposed
project and training. By the conclusion of this program, Dr. Haff will be able to independently
design, target, and evaluate interventions for cardiometabolic disease. The results of the
proposed K23 will be invaluable pilot work for a planned R01-level application.
近二分之一的美国成年人患有高血压,这是心肌梗塞的主要原因,
中风和死亡。尽管高血压很重要并且广泛存在
通过药物治疗,2018年只有44%的患者控制了血压。这是在
部分原因在于我们提供护理的方式,需要新的策略来实现更好的目标
血压控制。由非医生进行药物滴定的基于团队的护理是一种
有前途的方法,但所需的成本和基础设施使这种选择不太可行。一个
另一种策略是让患者通过检查血液来自我管理高血压
压力并遵循患者和初级保健医生之间预先计划的算法,
在家加强药物治疗。尽管有证据表明其有效性和成本-
这种方法的有效性,目前还没有被纳入日常护理中。
在这个项目中,我们建议开发一种可供实施的抗高血压自我滴定法
通过定性访谈和抗高血压药物的真实评估进行干预
坚持。拟议的目标是:(1)探索实施的障碍和促进因素
美国常规初级保健中抗高血压自行滴定的研究; (2) 评估遵守情况
抗高血压治疗; (3) 制定可供实施的抗高血压自我治疗方案
滴定方案,进行可用性测试,并准备一份实用的、随机的提案
试验来测试干预措施的有效性。该项目的总体目标是开发一个
高血压护理的创新替代模式有改善血液的潜力
压力控制、患者自我效能和疾病理解
哈夫博士是一名执业初级保健医生,致力于研究以改善
心脏代谢疾病的预防和治疗,该提案包括培训计划
这将加速她在实施科学、定性领域的职业发展
方法、卫生服务研究方法和科学写作。导师团队由
Niteesh Choudhry,卫生服务研究和实施科学方面的专家
心脏代谢疾病,包括预防心脏病学领域的知名专家(Paul Ridker,共同
导师)、生物统计学(罗伯特·格林,共同导师)以及实施科学和定性
方法(凯伦·埃蒙斯,联合导师),并将确保成功完成拟议的
项目和培训。完成该计划后,哈夫博士将能够独立
设计、瞄准和评估心脏代谢疾病的干预措施。结果
拟议的 K23 对于计划的 R01 级应用来说将是非常宝贵的试点工作。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Frequency of Quarterly Self-reported Health-Related Social Needs Among Older Adults, 2020.
- DOI:10.1001/jamanetworkopen.2022.19645
- 发表时间:2022-06-01
- 期刊:
- 影响因子:13.8
- 作者:Haff, Nancy;Choudhry, Niteesh K.;Bhatkhande, Gauri;Li, Yong;Antol, Dana Drzayich;Renda, Andrew;Lauffenburger, Julie C.
- 通讯作者:Lauffenburger, Julie C.
Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study.
- DOI:10.1186/s12877-023-04640-4
- 发表时间:2024-01-10
- 期刊:
- 影响因子:4.1
- 作者:Bhatkhande, Gauri;Choudhry, Niteesh K.;Mahesri, Mufaddal;Haff, Nancy;Lauffenburger, Julie C.
- 通讯作者:Lauffenburger, Julie C.
Gabapentinoid Use by Self-Reported Indication and Level of Evidence.
根据自我报告的适应症和证据水平使用加巴喷丁。
- DOI:10.1007/s11606-023-08418-7
- 发表时间:2024
- 期刊:
- 影响因子:5.7
- 作者:Chaitoff,Alexander;Choudhry,NiteeshK;Haff,Nancy;Lauffenburger,JulieC
- 通讯作者:Lauffenburger,JulieC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy Haff其他文献
Nancy Haff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy Haff', 18)}}的其他基金
Development of an implementation-ready antihypertensive self-titration intervention to improve US blood pressure control
开发可立即实施的抗高血压自我滴定干预措施,以改善美国血压控制
- 批准号:
10524825 - 财政年份:2022
- 资助金额:
$ 17.26万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Fellowship Programs














{{item.name}}会员




